4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000006
Chief Financial Officer sold 77,000 shares at $13.69 ($1,053,814)
- Chief Financial Officer acquired 77,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2026-08-26 | Option exercise 10b5-1 | +52,000 | $4.36 | $226,720 | 121,828 | D |
| Piscitelli Dominic Chief Financial Officer | 2026-08-26 | Option exercise 10b5-1 | +25,000 | $6.00 | $150,000 | 146,828 | D |
| Piscitelli Dominic Chief Financial Officer | 2026-08-26 | Sale 10b5-1 | −77,000 | $13.69 | $1,053,814 | 69,828 | D |
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2026-08-26 | Option exercise · Stock Option (right to buy) 10b5-1 | −52,000 | 92,500 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2026-08-26 | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 120,000 | D | ||
| Open-market sales · 77,000 sh · avg $13.69 · $1,053,814 | |||||||
Loading xslF345X06/form4-08282026_080834.xml…